| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.37 | 0.04 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |